The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion Placing

12 Feb 2016 17:19

RNS Number : 9963O
FastForward Innovations Limited
12 February 2016
 

12 February 2016

FastForward Innovations Limited

Completion Placing

Admission of New Shares to trading on AIM

Further to its announcements on 28 January and 8 February 2016, the Board of FastForward Innovations Limited ("FastForward" or the "Company") is pleased to announce that it has today completed the placing of 37,426,901 new Ordinary Shares of 1p each (the "Placing Shares") at a price of £0.15 per Placing Share thereby raising US$8,000,000 (£5,614,035 at an exchange rate of £1:US$1.425, being the rate on the date the Company determined the terms of the placing) before expenses (the "Placing").

 

Current Net Asset Value (based on the issued share capital following the Placing)

 

The Company has invested £4.1 million (c. £0.03 per share) into seven investments to date and has, on completion of the Placing, £6.8 million (£0.05 per share) in liquid assets to fund working capital and further investments.

 

Mr. Lorne Abony, the Company's Chief Executive Officer, was pleased to close the Placing in difficult market conditions:

 

"I have had an opportunity to review the current investment portfolio and to work with colleague directors to further develop the Company's future strategy. It is my view, shared by the Board, that the investments made to date have enormous potential for significant shareholder value creation. Beyond this, preliminary analysis indicates that each company is delivering results ahead of their respective business plans and budgets.

 

I intend to provide a comprehensive market update in due course with greater detail around our strategy, specific investment criteria and about our investments and their respective prospects. It is however my goal to work with the Board in the first half of 2016 making opportunistic investments. The second half of 2016 will likely see a heavy emphasis on seeking to crystallize the value of those businesses at valuations well in excess of the value that FFWD acquired its interests; those exits could take the form of investments by third parties at higher valuations, IPO's or sales. I am very comfortable saying that I am truly excited by the management teams we have in place, the milestones that have been achieved, and the results we are seeing, and am very confident that value enhancing events in the near future will reflect positively on our Net Asset Value.

 

The Placing was significantly over subscribed. I appreciate the tremendous confidence shown in me and the rest of the board by new and existing shareholders to deliver them superior returns. Many of our new shareholders are themselves successful technology investors. Their support will further enhance our ability to discover and incubate new tech start ups for the benefit of all our shareholders."

 

Admission of the Placing Shares to AIM

 

The Placing Shares (which will rank pari passu with the existing Ordinary Shares) have been issued and allotted and accordingly, admission to trading on AIM is expected to commence at 8.00 a.m. on 18 February 2016.

 

The enlarged issued share capital of the Company following the issue of the Consideration Shares and the Placing Shares will be 134,108,445 Ordinary Shares with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.fstfwd.co or contact:

FastForward Innovations Limited Tel: +44 1481 810 100 Elysium Fund Management Limited

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396 James Biddle / Michael Cornish

Peterhouse Corporate Finance Limited (Broker) Tel: +44 (0) 20 7469 0930 Guy Miller / Lucy Williams

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Limited and the companies in which it invests. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMZNZNGVZM
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.